Period:
Draw Mode:
| Volume | 1,046,225 |
|
|||||
| News | - | ||||||
| Day High | 7.06 | Low High |
|||||
| Day Low | 6.69 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| BioCryst Pharmaceuticals Inc | BCRX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.38 | -5.37% | 6.70 | 14:17:49 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 7.05 | 6.69 | 7.06 | 7.08 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 10,402 | 1,046,225 | $ 6.88 | $ 7,194,618 | - | 6.62 - 14.50 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:19:10 | 1 | $ 6.701 | USD |
BioCryst Pharmaceuticals (BCRX) Options Flow Summary
BioCryst Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.27B | 189.49M | - | 270.83M | -247.12M | -1.30 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
BioCryst Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BCRX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 7.30 | 7.64 | 6.69 | 7.33 | 2,135,624 | -0.60 | -8.22% |
| 1 Month | 7.16 | 7.8199 | 6.68 | 7.16 | 2,604,693 | -0.46 | -6.42% |
| 3 Months | 6.96 | 7.95 | 6.62 | 7.21 | 2,565,026 | -0.26 | -3.74% |
| 6 Months | 8.31 | 9.065 | 6.62 | 7.59 | 2,644,202 | -1.61 | -19.37% |
| 1 Year | 12.86 | 14.50 | 6.62 | 9.32 | 2,764,450 | -6.16 | -47.9% |
| 3 Years | 3.43 | 19.99 | 3.36 | 10.93 | 3,795,212 | 3.27 | 95.34% |
| 5 Years | 7.32 | 19.99 | 1.38 | 8.13 | 3,773,244 | -0.62 | -8.47% |
BioCryst Pharmaceuticals Description
| BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, with the aim of blocking key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology. |